Global AI-Enabled Imaging Modalities Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI09242460

Publication Date:

September 23, 2024

Pages:

105

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global AI-Enabled Imaging Modalities market size was valued at US$ million in 2023. With growing demand in downstream market, the AI-Enabled Imaging Modalities is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global AI-Enabled Imaging Modalities market. AI-Enabled Imaging Modalities are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of AI-Enabled Imaging Modalities. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the AI-Enabled Imaging Modalities market.
AI-Enabled听Imaging听Modalities help to automate and standardize not only workflows but also complex diagnostics to meet the needs of the individual patient. AI-Enabled听Imaging听Modalities develop with a kind of specific advanced algorithm to improve the accuracy of diagnosis and reduce the time required for diagnosis, helping doctors interpret chest radiographs.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Key Features:
The report on AI-Enabled Imaging Modalities market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the AI-Enabled Imaging Modalities market. It may include historical data, market segmentation by Type (e.g., Computed Tomography (CT), MRI), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the AI-Enabled Imaging Modalities market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the AI-Enabled Imaging Modalities market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the AI-Enabled Imaging Modalities industry. This include advancements in AI-Enabled Imaging Modalities technology, AI-Enabled Imaging Modalities new entrants, AI-Enabled Imaging Modalities new investment, and other innovations that are shaping the future of AI-Enabled Imaging Modalities.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the AI-Enabled Imaging Modalities market. It includes factors influencing customer ' purchasing decisions, preferences for AI-Enabled Imaging Modalities product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the AI-Enabled Imaging Modalities market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting AI-Enabled Imaging Modalities market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the AI-Enabled Imaging Modalities market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the AI-Enabled Imaging Modalities industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the AI-Enabled Imaging Modalities market.
Market Segmentation:
AI-Enabled Imaging Modalities market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Computed Tomography (CT)
MRI
X-Ray
Ultrasound
Positron Emission Tomography (PET)
Other Modalities
Segmentation by application
Cardiology
Oncology
Neurology
Pulmonology
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Koninklijke Philips N.V.
Siemens Healthineers AG.
General Electric Company
Canon, Inc.
Agfa
Hologic
Fujifilm
Konica Minolta, Inc.
United Health Imaging
Exo
Nanox
Butterfly Network, Inc.
Hyperfine

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global AI-Enabled Imaging Modalities Market Size 2019-2030
2.1.2 AI-Enabled Imaging Modalities Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 AI-Enabled Imaging Modalities Segment by Type
2.2.1 Computed Tomography (CT)
2.2.2 MRI
2.2.3 X-Ray
2.2.4 Ultrasound
2.2.5 Positron Emission Tomography (PET)
2.2.6 Other Modalities
2.3 AI-Enabled Imaging Modalities Market Size by Type
2.3.1 AI-Enabled Imaging Modalities Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global AI-Enabled Imaging Modalities Market Size Market Share by Type (2019-2024)
2.4 AI-Enabled Imaging Modalities Segment by Application
2.4.1 Cardiology
2.4.2 Oncology
2.4.3 Neurology
2.4.4 Pulmonology
2.4.5 Others
2.5 AI-Enabled Imaging Modalities Market Size by Application
2.5.1 AI-Enabled Imaging Modalities Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global AI-Enabled Imaging Modalities Market Size Market Share by Application (2019-2024)
3 AI-Enabled Imaging Modalities Market Size by Player
3.1 AI-Enabled Imaging Modalities Market Size Market Share by Players
3.1.1 Global AI-Enabled Imaging Modalities Revenue by Players (2019-2024)
3.1.2 Global AI-Enabled Imaging Modalities Revenue Market Share by Players (2019-2024)
3.2 Global AI-Enabled Imaging Modalities Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 AI-Enabled Imaging Modalities by Regions
4.1 AI-Enabled Imaging Modalities Market Size by Regions (2019-2024)
4.2 Americas AI-Enabled Imaging Modalities Market Size Growth (2019-2024)
4.3 APAC AI-Enabled Imaging Modalities Market Size Growth (2019-2024)
4.4 Europe AI-Enabled Imaging Modalities Market Size Growth (2019-2024)
4.5 Middle East & Africa AI-Enabled Imaging Modalities Market Size Growth (2019-2024)
5 Americas
5.1 Americas AI-Enabled Imaging Modalities Market Size by Country (2019-2024)
5.2 Americas AI-Enabled Imaging Modalities Market Size by Type (2019-2024)
5.3 Americas AI-Enabled Imaging Modalities Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC AI-Enabled Imaging Modalities Market Size by Region (2019-2024)
6.2 APAC AI-Enabled Imaging Modalities Market Size by Type (2019-2024)
6.3 APAC AI-Enabled Imaging Modalities Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe AI-Enabled Imaging Modalities by Country (2019-2024)
7.2 Europe AI-Enabled Imaging Modalities Market Size by Type (2019-2024)
7.3 Europe AI-Enabled Imaging Modalities Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa AI-Enabled Imaging Modalities by Region (2019-2024)
8.2 Middle East & Africa AI-Enabled Imaging Modalities Market Size by Type (2019-2024)
8.3 Middle East & Africa AI-Enabled Imaging Modalities Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global AI-Enabled Imaging Modalities Market Forecast
10.1 Global AI-Enabled Imaging Modalities Forecast by Regions (2025-2030)
10.1.1 Global AI-Enabled Imaging Modalities Forecast by Regions (2025-2030)
10.1.2 Americas AI-Enabled Imaging Modalities Forecast
10.1.3 APAC AI-Enabled Imaging Modalities Forecast
10.1.4 Europe AI-Enabled Imaging Modalities Forecast
10.1.5 Middle East & Africa AI-Enabled Imaging Modalities Forecast
10.2 Americas AI-Enabled Imaging Modalities Forecast by Country (2025-2030)
10.2.1 United States AI-Enabled Imaging Modalities Market Forecast
10.2.2 Canada AI-Enabled Imaging Modalities Market Forecast
10.2.3 Mexico AI-Enabled Imaging Modalities Market Forecast
10.2.4 Brazil AI-Enabled Imaging Modalities Market Forecast
10.3 APAC AI-Enabled Imaging Modalities Forecast by Region (2025-2030)
10.3.1 China AI-Enabled Imaging Modalities Market Forecast
10.3.2 Japan AI-Enabled Imaging Modalities Market Forecast
10.3.3 Korea AI-Enabled Imaging Modalities Market Forecast
10.3.4 Southeast Asia AI-Enabled Imaging Modalities Market Forecast
10.3.5 India AI-Enabled Imaging Modalities Market Forecast
10.3.6 Australia AI-Enabled Imaging Modalities Market Forecast
10.4 Europe AI-Enabled Imaging Modalities Forecast by Country (2025-2030)
10.4.1 Germany AI-Enabled Imaging Modalities Market Forecast
10.4.2 France AI-Enabled Imaging Modalities Market Forecast
10.4.3 UK AI-Enabled Imaging Modalities Market Forecast
10.4.4 Italy AI-Enabled Imaging Modalities Market Forecast
10.4.5 Russia AI-Enabled Imaging Modalities Market Forecast
10.5 Middle East & Africa AI-Enabled Imaging Modalities Forecast by Region (2025-2030)
10.5.1 Egypt AI-Enabled Imaging Modalities Market Forecast
10.5.2 South Africa AI-Enabled Imaging Modalities Market Forecast
10.5.3 Israel AI-Enabled Imaging Modalities Market Forecast
10.5.4 Turkey AI-Enabled Imaging Modalities Market Forecast
10.5.5 GCC Countries AI-Enabled Imaging Modalities Market Forecast
10.6 Global AI-Enabled Imaging Modalities Forecast by Type (2025-2030)
10.7 Global AI-Enabled Imaging Modalities Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Koninklijke Philips N.V.
11.1.1 Koninklijke Philips N.V. Company Information
11.1.2 Koninklijke Philips N.V. AI-Enabled Imaging Modalities Product Offered
11.1.3 Koninklijke Philips N.V. AI-Enabled Imaging Modalities Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Koninklijke Philips N.V. Main Business Overview
11.1.5 Koninklijke Philips N.V. Latest Developments
11.2 Siemens Healthineers AG.
11.2.1 Siemens Healthineers AG. Company Information
11.2.2 Siemens Healthineers AG. AI-Enabled Imaging Modalities Product Offered
11.2.3 Siemens Healthineers AG. AI-Enabled Imaging Modalities Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Siemens Healthineers AG. Main Business Overview
11.2.5 Siemens Healthineers AG. Latest Developments
11.3 General Electric Company
11.3.1 General Electric Company Company Information
11.3.2 General Electric Company AI-Enabled Imaging Modalities Product Offered
11.3.3 General Electric Company AI-Enabled Imaging Modalities Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 General Electric Company Main Business Overview
11.3.5 General Electric Company Latest Developments
11.4 Canon, Inc.
11.4.1 Canon, Inc. Company Information
11.4.2 Canon, Inc. AI-Enabled Imaging Modalities Product Offered
11.4.3 Canon, Inc. AI-Enabled Imaging Modalities Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Canon, Inc. Main Business Overview
11.4.5 Canon, Inc. Latest Developments
11.5 Agfa
11.5.1 Agfa Company Information
11.5.2 Agfa AI-Enabled Imaging Modalities Product Offered
11.5.3 Agfa AI-Enabled Imaging Modalities Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Agfa Main Business Overview
11.5.5 Agfa Latest Developments
11.6 Hologic
11.6.1 Hologic Company Information
11.6.2 Hologic AI-Enabled Imaging Modalities Product Offered
11.6.3 Hologic AI-Enabled Imaging Modalities Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Hologic Main Business Overview
11.6.5 Hologic Latest Developments
11.7 Fujifilm
11.7.1 Fujifilm Company Information
11.7.2 Fujifilm AI-Enabled Imaging Modalities Product Offered
11.7.3 Fujifilm AI-Enabled Imaging Modalities Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Fujifilm Main Business Overview
11.7.5 Fujifilm Latest Developments
11.8 Konica Minolta, Inc.
11.8.1 Konica Minolta, Inc. Company Information
11.8.2 Konica Minolta, Inc. AI-Enabled Imaging Modalities Product Offered
11.8.3 Konica Minolta, Inc. AI-Enabled Imaging Modalities Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Konica Minolta, Inc. Main Business Overview
11.8.5 Konica Minolta, Inc. Latest Developments
11.9 United Health Imaging
11.9.1 United Health Imaging Company Information
11.9.2 United Health Imaging AI-Enabled Imaging Modalities Product Offered
11.9.3 United Health Imaging AI-Enabled Imaging Modalities Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 United Health Imaging Main Business Overview
11.9.5 United Health Imaging Latest Developments
11.10 Exo
11.10.1 Exo Company Information
11.10.2 Exo AI-Enabled Imaging Modalities Product Offered
11.10.3 Exo AI-Enabled Imaging Modalities Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Exo Main Business Overview
11.10.5 Exo Latest Developments
11.11 Nanox
11.11.1 Nanox Company Information
11.11.2 Nanox AI-Enabled Imaging Modalities Product Offered
11.11.3 Nanox AI-Enabled Imaging Modalities Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Nanox Main Business Overview
11.11.5 Nanox Latest Developments
11.12 Butterfly Network, Inc.
11.12.1 Butterfly Network, Inc. Company Information
11.12.2 Butterfly Network, Inc. AI-Enabled Imaging Modalities Product Offered
11.12.3 Butterfly Network, Inc. AI-Enabled Imaging Modalities Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Butterfly Network, Inc. Main Business Overview
11.12.5 Butterfly Network, Inc. Latest Developments
11.13 Hyperfine
11.13.1 Hyperfine Company Information
11.13.2 Hyperfine AI-Enabled Imaging Modalities Product Offered
11.13.3 Hyperfine AI-Enabled Imaging Modalities Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Hyperfine Main Business Overview
11.13.5 Hyperfine Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂